iBio Statistics
NASDAQ: IBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.8001-0.0009 (-0.11%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
iBio by the numbers
iBio has a market capitalization of $56.4 million based on 70.46M shares outstanding. With trailing EPS of $-0.27, iBio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.0% below its 50-day average and 49.5% below its 200-day average.
Average daily trading volume is 678.91K shares, or about $543,195 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IBIO valuation vs. peer median
| Metric | IBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $56.37M | $54.89M | +3% |
| Avg. volume | 678.91K | 122.68K | +453% |
Peer median across 8 companies: KZIA, TENX, AZR, BOLD, RANI, XLO, CTOR, XBIT.
Valuation
- Market cap
- $56.37M
- Price / sales (latest FY)
- 563.72
- EPS (TTM)
- $-0.27
- Shares outstanding
- 70.46M
Price and trading
- Previous close
- 0.801
- Open
- 0.7955
- Day range
- 0.7626 – 0.8266
- 52-week range
- 0.68 – 3.82
- 52-week change
- -23.80%
- 50-day moving average
- 0.9308
- Beta
- —
- Volume
- 3.36M
- Average volume
- 678.91K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 18, 2025
Additional statistics
- Market Cap
- 56.37M
- Forward Pe
- -1.54
- Eps
- -0.27
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.82
- Week52 Low
- 0.68
- Avg Volume
- 678.91K
- Shares Outstanding
- 70.46M
- Ma50
- 0.93
- Ma200
- 1.58
- Earnings Date
- Sep 18, 2025
- Pct From52w High
- -79.05%
- Pct From52w Low
- 17.66%